s6y
Company name or ticker
Search
Scribe Therapeutics, Inc.
4
Avoro Capital Advisors LLC: Statement of changes in beneficial ownership of securities
Filed
Tuesday, July 28, 2026
Period
Jul 24, 2026
Accession number
0000902664-26-003270
Documents
ownership.xml
4
On sec.gov
Filing index
All files
Complete submission text
SGML header